- Market Capitalization, $K 3,311,464
- Shares Outstanding, K 371,657
- Annual Sales, $ 46,720 K
- Annual Income, $ -73,140 K
- 60-Month Beta 1.79
- Price/Sales 69.69
- Price/Cash Flow N/A
- Price/Book 2.14
|Period||Period Low||Period High||Performance|
| || |
+1.53 (+20.73%)since 05/11/21
| || |
-1.57 (-14.98%)since 03/11/21
| || |
+2.49 (+38.79%)since 06/11/20
/PRNewswire/ -- Cannabidiol (CBD) extract is a product that's derived from cannabis. It's a type of cannabinoid, which are the chemicals naturally found in marijuana plants. Even though it comes from marijuana...
Cannabis stocks have staged a rousing return in recent weeks after a quiet first half of 2021. Sales are on the rise this year as revenue and profits for many cannabis companies have increased significantly....
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group"), an innovative global cannabinoid company, and Ginkgo Bioworks, Inc. ("Ginkgo"), which is building the leading horizontal platform for cell...
, /PRNewswire/ -- Over the past few years the legalization of marijuana has spurred the industry's growth in both medicinal and recreational markets and the growth appears that it will continue to substantially...
Tomorrow brings us our first steady diet of useful economic data of the week, with both normal Thursday Initial Jobless Claims and ADP (ADP) private-sector payrolls.
, /PRNewswire/ -- While the pandemic has been terrible for many industries and businesses, the cannabis market turned out to be an unexpected winner. In 2020, legal cannabis sales in the U.S were up 46%...
Cronos (CRON) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the...
, /PRNewswire/ -- Today, the world seeing the beginning of the next great biotech boom... and it has nothing to do with COVID-19. Thanks to new laws sweeping , there might be a groundbreaking new opportunity...
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company"), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, will speak at Canaccord...
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company") today released a Marketing Code designed to responsibly move the emerging cannabis industry forward. Cronos Group believes...
|Cronos Group Inc|
|FTSE Developed Markets Vanguard|
|FTSE All-World Ex-US Smcp Idx ETF Vanguard|
|Amplify Seymour Cannabis ETF|
|Total Intl Stock ETF Vanguard|
|Advisorshares Pure Cannabis ETF|